Literature DB >> 12810805

Prolonged survival in motor neuron disease: a descriptive study of the King's database 1990-2002.

M R Turner1, M J Parton, C E Shaw, P N Leigh, A Al-Chalabi.   

Abstract

Motor neuron disease is a clinically heterogeneous disease with significant differences in survival. The authors have characterised a subset of long term survivors seen in a tertiary clinic over a 12 year period in terms of clinical variables and demographics, comparing them with short term survivors and the remaining population. Thirty of 769 patients survived more than 10 years, corresponding to 4% of the total population. Significantly younger onset of disease symptoms and a predominance of pure upper motor neuron signs at presentation characterised the long term survivors, but factors traditionally regarded as being associated with poor prognosis were also well represented. For a few people with motor neuron disease there remains the hope, whatever the initial presentation, that their subsequent survival will be longer than expected.

Entities:  

Mesh:

Year:  2003        PMID: 12810805      PMCID: PMC1738535          DOI: 10.1136/jnnp.74.7.995

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  37 in total

1.  Patients who survive 5 years or more with ALS in Olmsted County, 1925-2004.

Authors:  Farrah J Mateen; Marco Carone; Eric J Sorenson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-07-13       Impact factor: 10.154

2.  Birth order and the genetics of amyotrophic lateral sclerosis.

Authors:  Umesh Vivekananda; Clare Johnston; Diane McKenna-Yasek; Christopher E Shaw; P Nigel Leigh; Robert H Brown; Ammar Al-Chalabi
Journal:  J Neurol       Date:  2007-12-19       Impact factor: 4.849

3.  Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease.

Authors:  S Fadilah Abdul Wahid; Zhe Kang Law; Nor Azimah Ismail; Nai Ming Lai
Journal:  Cochrane Database Syst Rev       Date:  2019-12-19

4.  The effect of autologous bone marrow mononuclear cell transplantation on the survival duration in Amyotrophic Lateral Sclerosis - a retrospective controlled study.

Authors:  Alok K Sharma; Hemangi M Sane; Amruta A Paranjape; Nandini Gokulchandran; Anjana Nagrajan; Myola D'sa; Prerna B Badhe
Journal:  Am J Stem Cells       Date:  2015-03-15

Review 5.  Quo vadis motor neuron disease?

Authors:  Rubika Balendra; Rickie Patani
Journal:  World J Methodol       Date:  2016-03-26

6.  Amyotrophic lateral sclerosis: early predictors of prolonged survival.

Authors:  Adam Czaplinski; Albert A Yen; Stanley H Appel
Journal:  J Neurol       Date:  2006-06-13       Impact factor: 4.849

7.  New considerations in the design of clinical trials for amyotrophic lateral sclerosis.

Authors:  James D Berry; Merit E Cudkowicz
Journal:  Clin Investig (Lond)       Date:  2011-10

8.  Pattern of spread and prognosis in lower limb-onset ALS.

Authors:  Martin R Turner; Alice Brockington; Jakub Scaber; Hannah Hollinger; Rachael Marsden; Pamela J Shaw; Kevin Talbot
Journal:  Amyotroph Lateral Scler       Date:  2010-08

Review 9.  Prognostic factors in ALS: A critical review.

Authors:  Adriano Chiò; Giancarlo Logroscino; Orla Hardiman; Robert Swingler; Douglas Mitchell; Ettore Beghi; Bryan G Traynor
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec

Review 10.  Amyotrophic lateral sclerosis.

Authors:  Lokesh C Wijesekera; P Nigel Leigh
Journal:  Orphanet J Rare Dis       Date:  2009-02-03       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.